In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone 
Metabolites of Albendazole, Triclabendazole, Aldicarb, Methiocarb, Montelukast and Ziprasidone

BACKGROUND: The use of polypharmacy in the present day clinical therapy has made the identification of clinical drug-drug interaction risk an important aspect of drug development process. Although many drugs can be metabolized to sulfoxide and/or sulfone metabolites, seldom is known on the CYP in-hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Giri, Poonam, Gupta, Lakshmikant, Naidu, Sneha, Joshi, Vipul, Patel, Nirmal, Giri, Shyamkumar, Srinivas, Nuggehally R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416464/
https://www.ncbi.nlm.nih.gov/pubmed/30117405
http://dx.doi.org/10.2174/1872312812666180816164626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416464/
https://www.ncbi.nlm.nih.gov/pubmed/30117405
http://dx.doi.org/10.2174/1872312812666180816164626

Ejemplares similares